Yes I do Charts. Appears to be beginning to consolidate and then continue its Upward Trend. I also notice Shorts have reinvested again. I believe this is very foolish and they will regret. Overall Short Covering will continue as SP increases overall. I have followed with interest Mithra Pharma They had AGM last Friday. A$1.5B Company and their Revenue only 25% of Mayne. On top of that the Major Portion of Their Revenue is income derived from Mayne. Even so much as since 17April FDA filing E4 Mithra Shares have risen 17%. The European Investors appear to appreciate value of future income in USA more than our local short term players. Better Leadership at Mayne could have stopped this , but The Proof will be Forthcoming.
MYX Price at posting:
39.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)